
    
      A Phase 1, Randomized, Placebo Controlled, Crossover Trial in Type 2 Diabetes Patients to
      evaluate the effect of pre-meal dosing time, inter-meal interval and meal composition on the
      PK and PD of IN-105 (Insulin Tregopil), an oral insulin; conducted in 3 sequential cohorts in
      an adaptive manner .
    
  